Today: 3 April 2026
Subscribe

Marcin Frąckiewicz

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Ford Stock Plunges as Devastating Supplier Fire and Recalls Turn 2025 Into a Nightmare

Ford Stock Rattled by Factory Fire and EV Slowdown – What Happens Next?

Ford shares closed at $11.92 Friday, recovering slightly after a 7% plunge on Oct. 7 following a fire at a key aluminum supplier’s plant that threatens F-150 production. Analysts estimate the blaze could cost Ford up to $1 billion in 2025 earnings. The company faces record recalls this year, regulatory penalties, and deepening losses in its EV division. U.S. EV sales for Ford fell 31% in Q2, prompting job cuts and delayed production targets.
18 October 2025
··
BigBear.ai (BBAI) Stock Rockets 80% in 2025 – Is the Defense-AI Rally Just Beginning?

BigBear.ai’s Stock Skyrockets on Defense AI Deals – Is BBAI the Next Palantir? 🚀

BigBear.ai shares jumped 22% on Oct. 13 after announcing a military AI partnership, reaching $9 before closing at $7.42 on Oct. 17. The company secured new U.S. defense contracts but reported Q2 revenue down 18% to $32.5 million and a net loss of $228.6 million. Wall Street rates the stock Hold, with a $6 average target. BigBear ended Q2 with $390 million in cash and a $380 million backlog.
18 October 2025
···
BlackRock’s Big Bet Sends SELLAS Life Sciences (SLS) Stock Soaring – What’s Next for This Biotech?

BlackRock’s Big Bet Sends SELLAS Life Sciences (SLS) Stock Soaring – What’s Next for This Biotech?

SELLAS Life Sciences (NASDAQ: SLS) shares doubled year-to-date in 2025, closing at $2.14 on Oct. 17 after a 38% after-hours jump and hitting a 52-week high of $2.27. BlackRock disclosed a 5.4% stake in the company. Interim Phase 3 trial results for SELLAS’s lead cancer drug showed median survival over 13.5 months in AML patients. Final trial data is expected by year-end 2025.
18 October 2025
Virgin Galactic Rockets 15% on Space Tourism Buzz – Can SPCE Defy Gravity or Crash Back to Earth?

Virgin Galactic’s Wild October Ride: SPCE Stock Soars on Space Tourism Hype, Then Plummets – What’s Next?

Virgin Galactic shares fell nearly 8% on Oct. 17 to $4.08 after a mid-month rally, leaving the stock down about 33% in 2025 and 99% below all-time highs. The company settled a shareholder lawsuit for $2.9 million in September. It announced a 2027 suborbital research flight with Purdue University. Virgin Galactic reported a $67 million Q2 loss and has about 1.5 years of cash left.
18 October 2025
··
Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat’s Shocking Collapse: BYND Stock Crashes Below $1 Amid Debt Deal Chaos

Beyond Meat shares plunged nearly 60% in one day, closing at $0.65 on Oct. 17 after a debt-for-equity swap triggered a flood of 316 million new shares. Founder and CEO Ethan Brown resigned from the board as analysts warned of a “death spiral.” The company reported Q2 revenue down 20% year-over-year and a net loss of $33 million. Cash reserves have dwindled to $117 million against $1.2 billion in debt.
18 October 2025
·
New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NUAI) Skyrockets 185% on AI Data Center Buzz – Can the Tiny Stock Sustain the Hype?

New Era Energy & Digital (NASDAQ: NUAI) closed at $4.55 on Oct. 17, up 44% in one day and 186% in two weeks after announcing progress on its 1-gigawatt AI data center in Texas. The company regained Nasdaq compliance, ended plans for share dilution, and rebranded from helium to AI infrastructure in August. NUAI remains pre-revenue, with $0.7 million in annual sales and steep losses. The stock is up 1300% from its 52-week low.
18 October 2025
····
MindMed Stock Skyrockets on Psychedelic Breakthroughs – What’s Driving the MNMD Surge?

MindMed Stock Soars 15% to 52-Week High on Psychedelic Breakthrough – What’s Next for MNMD?

MindMed (NASDAQ: MNMD) closed at $13.65 on Oct. 17, up 14.6% in one day and 68% year-to-date, after its LSD-based therapy MM120 showed strong Phase 2b results for Generalized Anxiety Disorder. The FDA granted Breakthrough Therapy status to MM120, with three Phase 3 trials underway. Needham & Co. initiated coverage with a Buy rating and $28 target. MindMed holds $237.9 million in cash, funding operations into 2027.
18 October 2025
··
Gilead Sciences (GILD) Stock Soars on Patent Victory, HIV Breakthroughs, and Analyst Upgrades

Gilead Sciences Stock Soars on Patent Win and HIV Breakthroughs – Will the Rally Continue?

Gilead Sciences stock jumped over 4% on Oct. 17, 2025, closing at $122.81 and hitting a new 52-week high. The surge follows a patent settlement extending exclusivity for Biktarvy until 2036 and FDA approval of Yeztugo, a new HIV prevention shot. Gilead’s market cap stands near $150 billion after a 47% year-to-date gain. Analysts remain bullish but note concerns over U.S. drug pricing pressures.
18 October 2025
···
Liberty Energy’s Rollercoaster: LBRT Surges on Earnings Despite Oilfield Headwinds

Liberty Energy (LBRT) Stock Soars 28% on Earnings Surprise – Can the Rally Last?

Liberty Energy Inc. shares surged 28% to $15.32 Friday after quarterly earnings, despite revenue falling 17% year-over-year and an adjusted net loss of $0.06 per share. The company posted a GAAP profit of $43 million due to one-off gains and raised its dividend by 13%. The stock remains well below its early-2025 highs after a steep year-to-date decline. Oilfield activity slowed sharply in 2025, hitting Liberty’s core business.
18 October 2025
···
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics (RANI) Stock Nearly Triples on $1B Chugai Deal – What Investors Should Know

Rani Therapeutics shares surged 248% to close at $1.64 on Oct. 17 after announcing a collaboration with Chugai Pharmaceutical worth up to $1.08 billion. The deal includes $10 million upfront and up to $175 million in milestones for the first drug. Rani also raised $60.3 million in a private placement, extending its cash runway into 2028. The company’s RaniPill technology delivers injectable drugs via oral capsules.
18 October 2025
···
AGI Race Sparks ‘Alien Intelligence’ Fears as Experts Clash – Tech Stocks Soar Amid Superintelligence Hype

AGI Race Sparks ‘Alien Intelligence’ Fears as Experts Clash – Tech Stocks Soar Amid Superintelligence Hype

Tech companies including OpenAI, DeepMind, and Meta are spending over $325 billion by 2025 to develop artificial general intelligence, with leaders predicting AGI could arrive this decade. Some researchers warn superintelligent AI could escape human control and pose existential risks. Nvidia shares surged after a $100 billion investment in OpenAI, while Alphabet’s market value nears $3 trillion amid the AI boom.
18 October 2025
···
Gold Shatters Records Above $4,300 – Is $5,000 Next or a Pullback Coming?

Gold Shatters Records Above $4,300 – Is $5,000 Next or a Pullback Coming?

Gold hit a record $4,378 per ounce on October 17 before slipping to $4,210, still up nearly 5% for the week and 64% year-to-date. Silver also reached a record near $54. A comment from President Trump easing U.S.-China trade tensions triggered a late-week pullback, strengthening the dollar and prompting profit-taking. Markets expect a Fed rate cut in late October.
18 October 2025
Nasdaq’s Wild Week: Tech Titans Soar & Plunge as Volatility Spikes – What’s Next?

Nasdaq’s Wild Week: Tech Titans Soar & Plunge as Volatility Spikes – What’s Next?

The Nasdaq closed at 22,679.98 Friday, up 117 points, capping a volatile week near record highs. Nvidia shares retreated after hitting records, while AMD jumped 34% on an OpenAI chip deal. The KBW Regional Bank Index rebounded after sharp losses as banks addressed loan and fraud concerns. The VIX spiked to a six-month high before easing, with traders bracing for volatility ahead of major tech earnings and a delayed U.S. inflation report.
18 October 2025
·········
Bitcoin’s Uptober Rollercoaster: Price Sinks to $107K After Record Highs – What’s Next?

Bitcoin’s Uptober Rollercoaster: Price Sinks to $107K After Record Highs – What’s Next?

Bitcoin traded near $107,000 on Oct. 18, 2025, up 2.5% in 24 hours but down 7% for the week after hitting a record above $125,000 earlier this month. A surprise U.S.–China trade flare-up on Oct. 10 triggered a sharp sell-off, with Bitcoin dropping from $122,000 to $104,000 in hours. U.S. crypto funds saw $536 million in outflows Thursday, the largest since August. Ethereum hovered near $3,800 after falling from above $4,800.
18 October 2025
··
XRP Price Jumps Back After Wild Swing – Ripple’s Token Eyes ETF Catalyst in Volatile Crypto Market

XRP Price Jumps Back After Wild Swing – Ripple’s Token Eyes ETF Catalyst in Volatile Crypto Market

XRP traded near $2.35 on October 18, 2025, recovering from a 42% flash crash last week triggered by a U.S.–China tariff threat. The SEC ended its lawsuit against Ripple in August, clearing the way for U.S. exchanges to relist XRP and for ETF applications now awaiting SEC decisions. XRP’s market cap stands at about $140 billion, among the top five crypto assets. Bitcoin is under $107,000; Ethereum trades near $3,900.
18 October 2025
··
Solana (SOL) Price Rollercoaster: From $250 Uptober High to $185 – Will It Rebound to $300?

Solana (SOL) Price Rollercoaster: From $250 Uptober High to $185 – Will It Rebound to $300?

Solana traded at $185 on October 18, 2025, down sharply from highs above $250 earlier in the month as ETF hype faded. The pullback followed a broader crypto market decline, with Bitcoin near $106,700 and Ethereum around $3,855. Solana’s market cap remains above $110 billion, ranking it among the top six cryptocurrencies. Key support at $170–$180 is under pressure as traders watch for further moves.
18 October 2025
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 18.10.2025

Eaton Corporation received an 87% score under Validea’s Peter Lynch P/E/Growth strategy, passing key metrics for growth and valuation. Lululemon Athletica scored 79% in a Buffett-inspired analysis, meeting most fundamental criteria but missing on initial rate of return. Both are classified as large-cap growth stocks.
18 October 2025
·
1 … 229 230 231 232 233 … 361

Stock Market Today

  • Corcept Therapeutics (CORT) Shares Show Volatility, Discounted Cash Flow Model Suggests Undervaluation
    April 3, 2026, 3:08 PM EDT. Corcept Therapeutics (CORT) shares have been volatile, with a 10.3% gain over the last week and a 20.4% rise over 30 days. Despite a 46.5% drop in the past year, the stock is up 11.2% year to date and has returned over 85% across 3 and 5 years. A Discounted Cash Flow (DCF) model estimates an intrinsic value of $332.45 per share, compared to the recent price near $42.49, indicating the stock may be undervalued by 87.2%. This DCF model discounts future free cash flows to present value, factoring analyst estimates through 2030. Corcept scores 2 out of 6 on Simply Wall St's valuation checks, reflecting mixed signals amid recent optimism and underlying business reassessment.
Go toTop